Payment overview · 2025
General Payments
$258.34
2 reported records · 2 companies
Healthcare provider profile · identity verified
Fransisco Hernandez, M.D.
Allopathic & Osteopathic Physicians|Family Medicine · NEW BRAUNFELS, TX · NPI 1972569895
Verified facts
What the public records show
CMS Open Payments records show Fransisco Hernandez, M.D. received $258.34 in general payments during 2025 across 2 reported records.
SI-BONE, INC. accounted for 65.8% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| SI-BONE, INC. | Unresolved — no canonical attribution shown | $169.88 | 65.8% | 1 | 2025 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Unresolved — no canonical attribution shown | $88.46 | 34.2% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $258.34 | 2 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| LifeVest Normalized: lifevest |
Device | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $88.46 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
None of this doctor’s payer companies has same-entity product evidence that passes the publication threshold. The site does not infer company ownership, affiliates, or generic manufacturers.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 647 | 127 |
| Furosemide | Furosemide | 553 | 115 |
| Levothyroxine Sodium | Levothyroxine Sodium | 519 | 90 |
| Eliquis | Apixaban | 481 | 56 |
| Donepezil Hcl | Donepezil Hcl | 446 | 66 |
| Sertraline Hcl | Sertraline Hcl | 405 | 66 |
| Potassium Chloride | Potassium Chloride | 388 | 77 |
| Amlodipine Besylate | Amlodipine Besylate | 357 | 74 |
| Lisinopril | Lisinopril | 314 | 57 |
| Gabapentin | Gabapentin | 313 | 65 |
| Trazodone Hcl | Trazodone Hcl | 312 | 56 |
| Tramadol Hcl | Tramadol Hcl | 214 | 77 |
| Losartan Potassium | Losartan Potassium | 204 | 48 |
| Memantine Hcl | Memantine Hcl | 202 | 35 |
| Metoprolol Tartrate | Metoprolol Tartrate | 196 | 51 |
| Buspirone Hcl | Buspirone Hcl | 192 | 30 |
| Divalproex Sodium | Divalproex Sodium | 186 | 31 |
| Lorazepam | Lorazepam | 183 | 29 |
| Carvedilol | Carvedilol | 177 | 44 |
| Montelukast Sodium | Montelukast Sodium | 176 | 28 |
| Pantoprazole Sodium | Pantoprazole Sodium | 169 | 57 |
| Tamsulosin Hcl | Tamsulosin Hcl | 168 | 48 |
| Mirtazapine | Mirtazapine | 161 | 42 |
| Myrbetriq | Mirabegron | 160 | 13 |
| Clopidogrel | Clopidogrel Bisulfate | 159 | 43 |
| Levetiracetam | Levetiracetam | 146 | 23 |
| Xarelto | Rivaroxaban | 146 | 13 |
| Metoprolol Succinate | Metoprolol Succinate | 142 | 40 |
| Omeprazole | Omeprazole | 142 | 35 |
| Duloxetine Hcl | Duloxetine Hcl | 134 | 24 |
| Pregabalin | Pregabalin | 133 | 25 |
| Escitalopram Oxalate | Escitalopram Oxalate | 119 | 24 |
| Hydralazine Hcl | Hydralazine Hcl | 111 | 28 |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 110 | 26 |
| Fluticasone Propionate | Fluticasone Propionate | 105 | 26 |
| Tradjenta | Linagliptin | 102 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 101 | 11 |
| Amiodarone Hcl | Amiodarone Hcl | 92 | 34 |
| Quetiapine Fumarate | Quetiapine Fumarate | 92 | 13 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 90 | 13 |
| Hydrochlorothiazide | Hydrochlorothiazide | 90 | 18 |
| Metformin Hcl | Metformin Hcl | 84 | 24 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 84 | 12 |
| Spironolactone | Spironolactone | 84 | 23 |
| Alendronate Sodium | Alendronate Sodium | 74 | suppressed |
| Famotidine | Famotidine | 73 | 29 |
| Allopurinol | Allopurinol | 72 | 11 |
| Bumetanide | Bumetanide | 72 | 13 |
| Fluoxetine Hcl | Fluoxetine Hcl | 69 | 11 |
| Oxcarbazepine | Oxcarbazepine | 68 | suppressed |
| Finasteride | Finasteride | 67 | suppressed |
| Meloxicam | Meloxicam | 67 | 11 |
| Ropinirole Hcl | Ropinirole Hcl | 67 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 66 | 15 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 65 | 16 |
| Lamotrigine | Lamotrigine | 65 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 63 | 11 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 62 | 22 |
| Baclofen | Baclofen | 60 | 11 |
| Prednisone | Prednisone | 59 | 30 |
| Warfarin Sodium | Warfarin Sodium | 58 | suppressed |
| Lactulose | Lactulose | 57 | 18 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 56 | 32 |
| Midodrine Hcl | Midodrine Hcl | 56 | 17 |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 54 | 11 |
| Doxazosin Mesylate | Doxazosin Mesylate | 52 | suppressed |
| Medroxyprogesterone Acetate | Medroxyprogesterone Acetate | 51 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 51 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 49 | 21 |
| Levofloxacin | Levofloxacin | 48 | 29 |
| Olanzapine | Olanzapine | 47 | suppressed |
| Simvastatin | Simvastatin | 46 | suppressed |
| Aripiprazole | Aripiprazole | 44 | suppressed |
| Clonazepam | Clonazepam | 44 | suppressed |
| Latanoprost | Latanoprost | 43 | 11 |
| Sodium Chloride | 0.9 % Sodium Chloride | 43 | 24 |
| Glipizide | Glipizide | 42 | suppressed |
| Insulin Lispro | Insulin Lispro | 41 | suppressed |
| Alprazolam | Alprazolam | 40 | suppressed |
| Risperidone | Risperidone | 40 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 40 | suppressed |
| Ezetimibe | Ezetimibe | 37 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 36 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 36 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 36 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 35 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 33 | 11 |
| Doxepin Hcl | Doxepin Hcl | 32 | suppressed |
| Bupropion Xl | Bupropion Hcl | 31 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 31 | suppressed |
| Primidone | Primidone | 31 | suppressed |
| Scopolamine | Scopolamine | 30 | suppressed |
| Cephalexin | Cephalexin | 29 | 22 |
| Rivastigmine | Rivastigmine | 29 | suppressed |
| Cefuroxime | Cefuroxime Axetil | 28 | 27 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 28 | suppressed |
| Sevelamer Carbonate | Sevelamer Carbonate | 28 | suppressed |
| Trospium Chloride | Trospium Chloride | 28 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 27 | 12 |
| Jardiance | Empagliflozin | 27 | suppressed |
| Glyxambi | Empagliflozin/Linagliptin | 26 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 26 | suppressed |
| Topiramate | Topiramate | 26 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 25 | 23 |
| Januvia | Sitagliptin Phosphate | 25 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 25 | suppressed |
| Methocarbamol | Methocarbamol | 25 | 11 |
| Atenolol | Atenolol | 24 | suppressed |
| Cyproheptadine Hcl | Cyproheptadine Hcl | 24 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 24 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 24 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 23 | 14 |
| Ondansetron Odt | Ondansetron | 23 | 14 |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 23 | suppressed |
| Albuterol Sulfate | Albuterol Sulfate | 22 | suppressed |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 22 | 13 |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 22 | suppressed |
| Lubiprostone | Lubiprostone | 22 | suppressed |
| Amoxicillin | Amoxicillin | 21 | 13 |
| Entresto | Sacubitril/Valsartan | 21 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 20 | 19 |
| Diclofenac Sodium | Diclofenac Sodium | 20 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 19 | suppressed |
| Lacosamide | Lacosamide | 19 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 19 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 18 | suppressed |
| Ramipril | Ramipril | 18 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 17 | suppressed |
| Carbamazepine | Carbamazepine | 17 | suppressed |
| Cholestyramine | Cholestyramine (With Sugar) | 17 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 17 | suppressed |
| Lokelma | Sodium Zirconium Cyclosilicate | 17 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 17 | 14 |
| Nuplazid | Pimavanserin Tartrate | 17 | suppressed |
| Prazosin Hcl | Prazosin Hcl | 17 | suppressed |
| Sulfasalazine | Sulfasalazine | 17 | suppressed |
| Trimethoprim | Trimethoprim | 17 | suppressed |
| Valsartan | Valsartan | 17 | suppressed |
| Admelog Solostar | Insulin Lispro | 16 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 16 | suppressed |
| Cefdinir | Cefdinir | 16 | 13 |
| Divalproex Sodium Er | Divalproex Sodium | 16 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 16 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 16 | suppressed |
| Verapamil Hcl | Verapamil Hcl | 16 | suppressed |
| Cholestyramine Light | Cholestyramine | 15 | suppressed |
| Digoxin | Digoxin | 15 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 15 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 15 | suppressed |
| Torsemide | Torsemide | 15 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 15 | suppressed |
| Verapamil Er | Verapamil Hcl | 15 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 14 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 14 | suppressed |
| Cymbalta | Duloxetine Hcl | 14 | suppressed |
| Folic Acid | Folic Acid | 14 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 14 | suppressed |
| Azithromycin | Azithromycin | 13 | suppressed |
| Bydureon Bcise | Exenatide Microspheres | 13 | suppressed |
| Cilostazol | Cilostazol | 13 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 13 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 13 | suppressed |
| Insulin Aspart Flexpen | Insulin Aspart | 13 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 13 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 13 | suppressed |
| Metolazone | Metolazone | 13 | suppressed |
| Nifedipine Er | Nifedipine | 13 | suppressed |
| Nystatin | Nystatin | 13 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 13 | suppressed |
| Flecainide Acetate | Flecainide Acetate | 12 | suppressed |
| Levemir Flexpen | Insulin Detemir | 12 | suppressed |
| Lovastatin | Lovastatin | 12 | suppressed |
| Ozempic | Semaglutide | 12 | suppressed |
| Renacidin | Citric Ac/Gluconolact/Mag Carb | 12 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 12 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 11 | suppressed |
| Fenofibrate | Fenofibrate | 11 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 11 | suppressed |
| Mirabegron Er | Mirabegron | 11 | suppressed |
| Novolog | Insulin Aspart | 11 | suppressed |
| Zenpep | Lipase/Protease/Amylase | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $258.34 · 2 records | SI-BONE, INC. | LifeVest | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error